Сравнительная оценка метотрексата и инфликсимаба в сочетании с метотрексатом, используемых при лечении детей с полиартикулярной формой ювенильного идиопатического артрита

Кельцев Владимир Алексеевич, L.I. Grebenkina, Пыркова Светлана Александровна et al. · Kazan medical journal · 2011

Aim. To evaluate the effectiveness of treatment of children with polyarticular forms of juvenile idiopathic arthritis with infliximab in combination with methotrexate compared to methotrexate alone. Methods. Used were modern methods of immunologic monitoring, including determination of lymphocyte surface CD markers and level of the main cytokines. Individual efficacy of therapy in children was evaluated according to ACR-pedi criteria (a reduction by 30%, 50% and 70%). Infliximab in combination with methotrexate had a pronounced anti-inflammatory effect. In the case of administration methotrexate alone the efficacy of treatment of the juvenile idiopathic arthritis was either significantly lower or the treatment was not effective at all. Results. After 46 weeks of treatment with inf liximab+methotrexate in 81.2% of the patients clinical remission was achieved: the laboratory indicators of disease activity decreased, joint functions were completely restored and the quality of life improved, whereas during monotherapy with methotrexate remission was achieved in only 16% of cases. Conclusions. The obtained data make it possible to state the advisability of administering infliximab to children in the early stages of juvenile idiopathic arthritis in the event of non-effectiveness of methotrexate therapy during 1 3 months of treatment

Cited by 0 works.

Authors